Visterra Inc.
Charles Mitchell is a seasoned professional in the field of process development, currently serving as a Sr. Process Scientist at Visterra Inc. since October 2020, where responsibilities include leading cell line development and the creation of CHO cell lines for protein therapeutics. Previous experience includes roles as a Sr. Research Associate at Invaio Sciences, focusing on scalable Tangential Flow Filtration processes, and as a Process Engineer III at LakePharma, where design of flexible manufacturing processes for clinical trial biologics was key. Notable earlier positions include contributions at Amgen in monoclonal antibody manufacturing and as a NSF Graduate Research Fellow at MIT, where innovations in biomarker assays were achieved. Charles holds a Bachelor of Science in Chemical Engineering and Mathematics from Rensselaer Polytechnic Institute and has completed graduate courses at the Massachusetts Institute of Technology.
Visterra Inc.
1 followers
Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. andchanged its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.